Epigral Limited (NSE:EPIGRAL)

Market Cap	43.25B -44.6%
Revenue (ttm)	24.19B -1.2%
Net Income	3.38B -2.9%
EPS	78.35 -5.8%
Shares Out	43.14M
PE Ratio	12.80
Forward PE	14.45
Dividend	7.00 (0.71%)
Ex-Dividend Date	n/a

Volume	33,534
Average Volume	79,461
Open	1,002.00
Previous Close	1,002.50
Day's Range	984.90 - 1,005.90
52-Week Range	904.60 - 2,114.00
Beta	-0.34
RSI	40.14
Earnings Date	Jan 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 1,072
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In fiscal year 2025, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.